End-of-day quote
Shenzhen S.E.
06:00:00 2024-05-13 pm EDT
|
5-day change
|
1st Jan Change
|
6.82
CNY
|
-1.16%
|
|
-6.32%
|
-5.93%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
13,797
|
6,888
|
6,495
|
10,400
|
9,104
|
7,308
|
Enterprise Value (EV)
1 |
14,349
|
7,862
|
7,334
|
11,668
|
10,821
|
8,676
|
P/E ratio
|
35.5
x
|
22
x
|
68.6
x
|
38.4
x
|
51.5
x
|
36.8
x
|
Yield
|
0.28%
|
-
|
0.79%
|
0.3%
|
0.36%
|
0.52%
|
Capitalization / Revenue
|
2.17
x
|
1.02
x
|
0.93
x
|
1.56
x
|
1.14
x
|
1.05
x
|
EV / Revenue
|
2.25
x
|
1.16
x
|
1.04
x
|
1.75
x
|
1.35
x
|
1.25
x
|
EV / EBITDA
|
20.7
x
|
13.4
x
|
18.2
x
|
18.4
x
|
15.5
x
|
13.3
x
|
EV / FCF
|
-32.4
x
|
-14.5
x
|
4.2
x
|
-20.9
x
|
-41
x
|
24.5
x
|
FCF Yield
|
-3.09%
|
-6.89%
|
23.8%
|
-4.78%
|
-2.44%
|
4.08%
|
Price to Book
|
2.58
x
|
1.22
x
|
1.13
x
|
1.74
x
|
1.49
x
|
1.16
x
|
Nbr of stocks (in thousands)
|
1,055,598
|
1,024,998
|
945,426
|
945,426
|
945,426
|
945,426
|
Reference price
2 |
13.07
|
6.720
|
6.870
|
11.00
|
9.630
|
7.730
|
Announcement Date
|
4/9/18
|
4/26/19
|
4/29/20
|
4/29/21
|
4/29/22
|
4/26/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
6,369
|
6,776
|
7,022
|
6,652
|
7,999
|
6,945
|
EBITDA
1 |
692.6
|
588.5
|
404
|
634.3
|
699.9
|
650.8
|
EBIT
1 |
524.8
|
411
|
187.9
|
388.4
|
445.6
|
251.8
|
Operating Margin
|
8.24%
|
6.07%
|
2.68%
|
5.84%
|
5.57%
|
3.63%
|
Earnings before Tax (EBT)
1 |
481.5
|
403.3
|
156.9
|
338.1
|
333
|
420.2
|
Net income
1 |
388.9
|
319.7
|
102.7
|
271.1
|
176.7
|
198.8
|
Net margin
|
6.11%
|
4.72%
|
1.46%
|
4.08%
|
2.21%
|
2.86%
|
EPS
2 |
0.3684
|
0.3058
|
0.1002
|
0.2868
|
0.1869
|
0.2102
|
Free Cash Flow
1 |
-443.2
|
-541.5
|
1,745
|
-557.4
|
-264.1
|
353.7
|
FCF margin
|
-6.96%
|
-7.99%
|
24.85%
|
-8.38%
|
-3.3%
|
5.09%
|
FCF Conversion (EBITDA)
|
-
|
-
|
431.98%
|
-
|
-
|
54.35%
|
FCF Conversion (Net income)
|
-
|
-
|
1,699.54%
|
-
|
-
|
177.96%
|
Dividend per Share
2 |
0.0370
|
-
|
0.0540
|
0.0330
|
0.0350
|
0.0400
|
Announcement Date
|
4/9/18
|
4/26/19
|
4/29/20
|
4/29/21
|
4/29/22
|
4/26/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
552
|
974
|
839
|
1,268
|
1,716
|
1,368
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.7971
x
|
1.654
x
|
2.076
x
|
1.999
x
|
2.452
x
|
2.102
x
|
Free Cash Flow
1 |
-443
|
-542
|
1,745
|
-557
|
-264
|
354
|
ROE (net income / shareholders' equity)
|
7.88%
|
6.5%
|
2.32%
|
4.66%
|
5.56%
|
5.79%
|
ROA (Net income/ Total Assets)
|
2.9%
|
2.2%
|
1.01%
|
2.04%
|
2.17%
|
1.24%
|
Assets
1 |
13,422
|
14,540
|
10,161
|
13,260
|
8,135
|
15,976
|
Book Value Per Share
2 |
5.070
|
5.500
|
6.060
|
6.310
|
6.450
|
6.690
|
Cash Flow per Share
2 |
1.420
|
1.380
|
1.840
|
1.940
|
1.820
|
1.700
|
Capex
1 |
225
|
338
|
396
|
797
|
556
|
279
|
Capex / Sales
|
3.54%
|
4.98%
|
5.64%
|
11.98%
|
6.96%
|
4.01%
|
Announcement Date
|
4/9/18
|
4/26/19
|
4/29/20
|
4/29/21
|
4/29/22
|
4/26/23
|
|
1st Jan change
|
Capi.
|
---|
| -5.93% | 902M | | +5.92% | 105B | | -4.43% | 64.68B | | +60.48% | 43.21B | | +16.73% | 39.33B | | +6.77% | 32.99B | | +12.31% | 20.09B | | +13.41% | 17.05B | | +25.44% | 15.96B | | +5.80% | 14.69B |
Other Commodity Chemicals
|